Subscribe
shutterstock_406580500_jonathan_weiss
Jonathan Weiss / Shutterstock.com
21 October 2021Big PharmaAlex Baldwin

Eli Lilly can’t avoid royalties in insulin suit

Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies (RCT), an Arizona judge has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Big Pharma
Eli Lilly avoids sanctions in Teva migraine treatment dispute
13 January 2022   Teva Pharmaceuticals has failed to persuade a federal judge in Massachusetts that Eli Lilly should be penalised over its discovery search related to a patent dispute concerning a migraine treatment.
Americas
Teva can pursue migraine patent dispute against Eli Lilly
17 March 2022   Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Big Pharma
Eli Lilly avoids sanctions in Teva migraine treatment dispute
13 January 2022   Teva Pharmaceuticals has failed to persuade a federal judge in Massachusetts that Eli Lilly should be penalised over its discovery search related to a patent dispute concerning a migraine treatment.
Americas
Teva can pursue migraine patent dispute against Eli Lilly
17 March 2022   Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Big Pharma
Eli Lilly avoids sanctions in Teva migraine treatment dispute
13 January 2022   Teva Pharmaceuticals has failed to persuade a federal judge in Massachusetts that Eli Lilly should be penalised over its discovery search related to a patent dispute concerning a migraine treatment.
Americas
Teva can pursue migraine patent dispute against Eli Lilly
17 March 2022   Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?